Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 05, 2023

BUY
$0.24 - $0.53 $181 - $401
758 Added 4.04%
19,516 $4,000
Q2 2023

Aug 14, 2023

SELL
$0.44 - $0.73 $751 - $1,246
-1,708 Reduced 8.35%
18,758 $9,000
Q1 2023

Apr 14, 2023

SELL
$0.41 - $1.3 $333 - $1,058
-814 Reduced 3.83%
20,466 $10,000
Q4 2022

Feb 09, 2023

BUY
$1.1 - $50.0 $23,408 - $1.06 Million
21,280 New
21,280 $23,000

About Processa Pharmaceuticals, Inc.


  • Ticker PCSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,856,200
  • Market Cap $15.5M
  • Description
  • Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...
More about PCSA
Track This Portfolio

Track Mirador Capital Partners LP Portfolio

Follow Mirador Capital Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirador Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Mirador Capital Partners LP with notifications on news.